Choosing the Product Format for Aggrastat (tirofiban hydrochloride) Injection |
Creatinine Clearance Calculation Video for Aggrastat (tirofiban hydrochloride) Injection |
Educational Video on How to Use the 100 mL Vial for Delivery of Aggrastat (tirofiban hydrochloride) Injection |
Educational Video on How to Use the 100 or 250 mL Bag for Delivery of Aggrastat |
Educational Video on How to Use the 15 mL Bolus Vial in Combination with the 100 mL Vial of Aggrastat (tirofiban hydrochloride) InjectionEducational Video on How to Use the 15 mL bolus vial in combination with the 100 mL Product Formats of Aggrastat |
Indication:
Aggrastat® is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
Contraindications:
Warnings and Precautions:
Adverse Reactions:
For additional information, refer to the full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.FDA.gov/medwatch
or call 1-800-FDA-1088.